Home
Conditions
Amyotrophic Lateral Sclerosis

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

506 public trials 100 recruiting studies

Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Completed

Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study

NCT01639391

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Centre référent maladies rares SLA Paris, France

View Trial Details

Completed

Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01777646

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +11 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Completed

Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS

NCT01771640

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Royan Institute Tehran, Iran

View Trial Details

Completed

Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis

NCT03085706

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: The First Affiliated Hospital of Dalian Medical University Dalian, Liaoning, China

View Trial Details

Completed

Hypermetabolism in ALS Using Six REE Formulas

NCT03382392

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Limoges, France

View Trial Details

Completed

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

NCT01753076

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Grand Rapids, Michigan, United States

GSK Investigational Site Syracuse, New York, United States

GSK Investigational Site Columbus, Ohio, United States

View all 35 locations

View Trial Details

Completed

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

NCT02710162

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis, Creation of a ALS-specific Equation

NCT03378375

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: CHU LImoges Limoges, France

View Trial Details

Completed

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis

NCT02487407

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Charite Universitatsmedizin Berlin Berlin, Germany

Medical School Hannover Hanover, Germany

University Clinical Jena Jena, Germany

University Hospital of Ulm Ulm, Germany

View Trial Details

Completed

A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)

NCT02288091

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis trial results

Related conditions